These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29658620)

  • 21. The Effects of the Re-imposition of US Sanctions on Food Security in Iran.
    Hejazi J; Emamgholipour S
    Int J Health Policy Manag; 2022 May; 11(5):651-657. PubMed ID: 33160296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of sanctions on procurement of medicine and medical devices in Iran; a technical response.
    Hosseini SA
    Arch Iran Med; 2013 Dec; 16(12):736-8. PubMed ID: 24329148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparedness of primary and secondary health facilities in India to address major noncommunicable diseases: results of a National Noncommunicable Disease Monitoring Survey (NNMS).
    Krishnan A; Mathur P; Kulothungan V; Salve HR; Leburu S; Amarchand R; Nongkynrih B; Chaturvedi HK; Ganeshkumar P; K S VU; Laxmaiah A; Boruah M; Kumar S; Patro BK; Raghav PR; Rajkumar P; Sarma PS; Sharma R; Tambe M; Arlappa N; Mahanta TG; Bhuyan PJ; Joshi RP; Pakhare AP; Galhotra A; Kumar D; Behera BK; Topno RK; Gupta MK; Rustagi N; Trivedi AV; Thankappan KR; Gupta S; Garg S; Shelke SC; ; ;
    BMC Health Serv Res; 2021 Jul; 21(1):757. PubMed ID: 34332569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Service Readiness For Noncommunicable Diseases Was Low In Five Countries In 2013-15.
    Moucheraud C
    Health Aff (Millwood); 2018 Aug; 37(8):1321-1330. PubMed ID: 30080459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Availability and prices of medicines for non-communicable diseases at health facilities and retail drug outlets in Kenya: a cross-sectional survey in eight counties.
    Ashigbie PG; Rockers PC; Laing RO; Cabral HJ; Onyango MA; Buleti JPL; Wirtz VJ
    BMJ Open; 2020 May; 10(5):e035132. PubMed ID: 32414824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Access to essential medicines to treat chronic respiratory disease in low-income countries.
    Bissell K; Perrin C; Beran D
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):717-28. PubMed ID: 27155173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accessing medicines for non-communicable diseases: Patients and health care workers' experiences at public and private health facilities in Uganda.
    Tusubira AK; Akiteng AR; Nakirya BD; Nalwoga R; Ssinabulya I; Nalwadda CK; Schwartz JI
    PLoS One; 2020; 15(7):e0235696. PubMed ID: 32634164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender disparity and risk of noncommunicable disease among adults in Islamic Republic of Iran.
    Rahimi E; Mohammadi R; Mokhayeri Y; Nazari SS
    East Mediterr Health J; 2023 Aug; 29(8):630-637. PubMed ID: 37698218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health system to response to economic sanctions: global evidence and lesson learned from Iran.
    Sajadi HS; Majdzadeh R
    Global Health; 2022 Dec; 18(1):107. PubMed ID: 36581892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low utilisation of diabetes medicines in Iran, despite their affordability (2000-2012): a time-series and benchmarking study.
    Sarayani A; Rashidian A; Gholami K
    BMJ Open; 2014 Oct; 4(10):e005859. PubMed ID: 25324322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urbanization and noncommunicable disease (NCD) risk factors: WHO STEPwise Iranian NCD risk factors surveillance in 2011.
    Khorrami Z; Etemad K; Yarahmadi S; Khodakarim S; Kameli M; Hezaveh AM; Rahimi E
    East Mediterr Health J; 2017 Aug; 23(7):469-479. PubMed ID: 28853130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The experiences and perceptions of people with chronic and rare diseases during political-economic sanctions in Iran: a qualitative study.
    Kiani MM; Mostafavi H; Ebrahimi F; Majdzadeh R; Mohamadi E; Kraemer A; Olyaeemanesh A; Takian A
    BMC Health Serv Res; 2024 Mar; 24(1):276. PubMed ID: 38444030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Access to Medicines for Non-Communicable Diseases (NCDS) during COVID-19 in Kenya: A Descriptive Commentary.
    Kiragu ZW; Gathecha G; Mwangi MK; Ndegwa Z; Pastakia S; Nyagah D; Cizungu RN; Takah Mutwiri M; Ndolo M; Wirtz VJ
    Health Syst Reform; 2021 Jan; 7(1):e1984865. PubMed ID: 34748436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic sanctions against Iran as an important factor in threatening the health of patients with multiple sclerosis.
    Sahraian MA; Moghadasi AN; Eskandarieh S
    Curr J Neurol; 2021 Jan; 20(1):15-22. PubMed ID: 38011431
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China.
    Yang C; Hu S; Zhu Y; Zhu W; Li Z; Fang Y
    PLoS One; 2019; 14(10):e0223769. PubMed ID: 31618273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gaps in access to essential medicines and health products for noncommunicable diseases and mental health conditions.
    Minghui R; Simao M; Mikkelsen B; Kestel D; Ball A; Szilagyi Z
    Bull World Health Organ; 2020 Sep; 98(9):582-582A. PubMed ID: 33012854
    [No Abstract]   [Full Text] [Related]  

  • 37. Physical rehabilitation in Iran after international sanctions: explored findings from a qualitative study.
    Shahabi S; Teymourlouy AA; Shabaninejad H; Kamali M; Lankarani KB; Mojgani P
    Global Health; 2020 Sep; 16(1):86. PubMed ID: 32967707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coping with access barriers to non-communicable disease medicines: qualitative patient interviews in eight counties in Kenya.
    Ng G; Raskin E; Wirtz VJ; Banks KP; Laing RO; Kiragu ZW; Rockers PC; Onyango MA
    BMC Health Serv Res; 2021 May; 21(1):417. PubMed ID: 33941177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How Sanctions Have Impacted Iranian Healthcare Sector: A Brief Review.
    Akbarialiabad H; Rastegar A; Bastani B
    Arch Iran Med; 2021 Jan; 24(1):58-63. PubMed ID: 33588569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Insurance Gains and Losses With Access to Prescription Drugs.
    Yabroff KR; Kirby J; Zodet M
    JAMA Intern Med; 2017 Oct; 177(10):1531-1532. PubMed ID: 28892527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.